title: Intraabdominal follicular dendritic cell sarcoma: a report of three cases and review of the literature.
abstract: Follicular dendritic cell sarcoma (FDCS) is a rare neoplasm that originates from follicular dendritic cells in lymphoid follicles. FDCS has been increasingly reported in recent years. However, data on FDCS are mostly based on single case reports or case series and its natural history and standard treatment are not clear. To increase the understanding of this rare disease, we report our experience of three cases of FDCS with an analysis of the morphological and immunophenotypic characteristics, clinical course, treatment options and response to treatment. In addition, we reviewed the literature on FDCS.
authors.affiliation: Department of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Turkey. yukselurun@gmail.com
authors.forename: Yuksel
authors.initials: Y
authors.lastname: Urun
authors.forename: Duygu
authors.initials: D
authors.lastname: Kankaya
authors.forename: Lokman
authors.initials: L
authors.lastname: Koral
authors.forename: Bulent
authors.initials: B
authors.lastname: Yalcin
authors.forename: Ayca
authors.initials: A
authors.lastname: Karabork
authors.forename: Koray
authors.initials: K
authors.lastname: Ceyhan
authors.forename: Melih Cem
authors.initials: MC
authors.lastname: Boruban
authors.forename: Güngör
authors.initials: G
authors.lastname: Utkan
authors.forename: Ahmet
authors.initials: A
authors.lastname: Demirkazik
mesh_terms: D015746:Abdominal Pain / Q000209:etiology; D000315:Adrenalectomy; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis*; D017024:Chemotherapy, Adjuvant; D003125:Colostomy; D003520:Cyclophosphamide / Q000008:administration & dosage; D054740:Dendritic Cell Sarcoma, Follicular / Q000150:complications / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D003937:Diagnosis, Differential; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D046152:Gastrointestinal Stromal Tumors / Q000737:chemistry / Q000150:complications / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007150:Immunohistochemistry; D016130:Immunophenotyping; D008113:Liver Neoplasms / Q000737:chemistry / Q000150:complications / Q000175:diagnosis* / Q000556:secondary / Q000628:therapy*; D008297:Male; D008545:Melanoma / Q000737:chemistry / Q000150:complications / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D008551:Melena / Q000209:etiology; D008875:Middle Aged; D064847:Multimodal Imaging; D049268:Positron-Emission Tomography; D011241:Prednisone / Q000008:administration & dosage; D011351:Proctoscopy; D012004:Rectal Neoplasms / Q000737:chemistry / Q000150:complications / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D014057:Tomography, X-Ray Computed; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014408:Biomarkers, Tumor; D015251:Epirubicin; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone